FAM241A

mass-spec protein & survival
Survivalmass-specKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, FAM241A mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated FAM241A data layer compared with 26 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher FAM241A mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated FAM241A expression acts as an unfavorable survival marker, although some lineages such as LUAD and HNSC show a favorable association.

LSCC, LUAD, and HNSC are the cancer types where FAM241A mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
LSCCOSMedianII,III,IV0.6000.870.0113view →
LUADOSMedianAll0.8410.616.0402view →
HNSCOSQuartileAll0.8270.670.0441view →
Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

FAM241A–LSCC (OS)

Kaplan–Meier survival curve for FAM241A mass-spec protein-high vs -low samples in LSCC.

Open the LSCC breakdown →

Exploration